Sanctuary Advisors LLC Makes New $5.47 Million Investment in Astera Labs, Inc. $ALAB

Sanctuary Advisors LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 11,336 shares of the company’s stock, valued at approximately $5,475,000.

Other large investors have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in Astera Labs during the 2nd quarter worth $6,609,581,000. Atreides Management LP increased its stake in shares of Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after buying an additional 1,754,593 shares during the period. Amundi raised its holdings in Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after acquiring an additional 1,319,643 shares in the last quarter. Artisan Partners Limited Partnership purchased a new position in Astera Labs in the fourth quarter worth approximately $148,980,000. Finally, Goldman Sachs Group Inc. lifted its stake in Astera Labs by 189.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after acquiring an additional 858,693 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Astera Labs

In other news, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This represents a 7.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the transaction, the director directly owned 3,970 shares in the company, valued at approximately $1,237,965.10. This represents a 69.38% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is currently owned by insiders.

Analyst Ratings Changes

ALAB has been the topic of a number of analyst reports. JPMorgan Chase & Co. lifted their price target on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Roth Capital reiterated a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. TD Cowen cut their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research report on Wednesday, August 5th. Jefferies Financial Group boosted their target price on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Finally, Susquehanna upped their price target on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a report on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $333.00.

Astera Labs Stock Performance

Astera Labs stock opened at $277.53 on Tuesday. The firm has a market capitalization of $48.15 billion, a price-to-earnings ratio of 137.39 and a beta of 3.84. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The stock’s fifty day moving average is $350.46 and its two-hundred day moving average is $246.41.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same period last year, the company posted $0.44 EPS. The company’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.